Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis

NCT04317235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-03-23

No results posted yet for this study

Summary

Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries

Conditions

  • Diaphragmatic Paralysis

Interventions

DRUG

Ropivacaine 0.5% Injectable Solution

Is to put 3 ml or 5 ml and show the difference

Sponsors & Collaborators

  • Saint George Hospital

    lead OTHER

Principal Investigators

  • hazem kafrouni · Saint George Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-10
Primary Completion
2018-03-02
Completion
2019-01-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04317235 on ClinicalTrials.gov